This serves as a chronological record of your team's progress throughout the season. It documents your daily activities, experiments, discussions, and decisions.
Notebook Lead: Christian. The complete 15-day laboratory notebook covering ICCG-DoT, TfCa-DoG, and ScafGVT expression, purification, and activity assays.
OVERVIEW
Initiated IPTG-induction of two constructs simultaneously: pelB-ICCG-doT-8x (C30-1, in E. coli BL21 Rosetta™ DE3) and nosp-gvt-8x (C2-1, in E. coli BL21 DE3). Overnight starter cultures were diluted 1:100 into fresh expression medium and grown to the target OD600 before induction.
CONSTRUCTS & STRAINS
| Construct | Strain | Medium | IPTG | Target OD600 | Induction Temp. | Duration |
|---|---|---|---|---|---|---|
| pelB-ICCG-doT-8x (C30-1) | E. coli BL21 Rosetta™ DE3 | 2xYT + Kan50 | 0.9 mM | ~1.8 | 37°C | ~2 hr (pilot) |
| nosp-gvt-8x (C2-1) | E. coli BL21 DE3 | LB + 2mM CaCl2 + Kan50 | 0.2 mM | ~1.0 | 16°C | 19 hr |
PROCEDURE
Note: ICCG-doT was induced at a relatively high OD (~1.8) and at 37°C as a pilot to assess expression level. ScafGVT (nosp-gvt) was induced at 16°C to favour soluble periplasmic expression. Both cultures were left to express overnight.
OVERVIEW
Harvested ICCG-DoT and ScafGVT cell pellets from overnight expression. Expression results assessed by preliminary SDS-PAGE. Set up TfCa-DoG (nosp-TfCag-8x C14-1) induction for overnight expression.
ICCG-DOT & SCAFGVT HARVEST
Observation: Expression result review: ScafGVT (nosp-gvt) expression level met the requirement. ICCG-DoT (pelB-ICCGt) showed visible expression band by preliminary SDS-PAGE, though high background was noted in the Coomassie gel — consistent with high culture density at induction. Expression level adequate for downstream purification.
TFCA-DOG EXPRESSION SETUP
Note: TfCa-DoG was induced at high OD (3.5) to maximise cell density before switching to low-temperature expression. CaCl2 supplementation supports the Ca2+-dependent folding of the TfCa catalytic domain.
OVERVIEW
Performed Ni-NTA IMAC purification of ICCG-DoT and ScafGVT from clarified lysates. Harvested TfCa-DoG cell pellets and began lysis. Set up dialysis for eluted fractions overnight.
NI-NTA PURIFICATION — ICCG-DOT & SCAFGVT
TFCA-DOG HARVEST & LYSIS
Observation: Both ICCG-DoT (predicted 39.9 kDa) and ScafGVT (predicted 58.96 kDa) showed enriched bands at the expected molecular weights in the 250 mM imidazole elution fractions, confirmed by Coomassie staining of the collected fractions.
OVERVIEW
Ran SDS-PAGE (Coomassie Blue) and Western blot (anti-His) of ICCG-DoT and ScafGVT purification fractions to confirm protein identity. Simultaneously performed Ni-NTA purification of TfCa-DoG. Initiated dialysis of all three proteins overnight.
SDS-PAGE — ICCG-DOT (PROTEIN LOAD: 45 µL/WELL)
| Lane | Fraction | Expected Band | Observation |
|---|---|---|---|
| 1 | MW Marker | 10–100 kDa ladder | Standard ladder resolved |
| 2 | Pellet Lysate | 39.9 kDa (ICCG-DoT) | Multiple bands; 39.9 kDa band present |
| 3 | Culture Supernatant | — | Low protein — pelB targets periplasm, not medium |
| 4 | Protein Precipitate Input | 39.9 kDa | Dense band pattern; 39.9 kDa visible |
| 5 | Flow Through | — | Non-His-tagged host proteins; no 39.9 kDa |
| 6 | 50 mM Imidazole Wash | — | Contaminant removal; faint 39.9 kDa |
| 7 | 90 mM Imidazole Wash | — | Further wash; reduced background |
| 8 | 250 mM Imidazole Elute 1 | 39.9 kDa | Strong band at 39.9 kDa ✓ |
| 9 | 250 mM Imidazole Elute 2 | 39.9 kDa | Band at 39.9 kDa present |
| 10 | Dialysed Concentrate | 39.9 kDa | Dominant single band at 39.9 kDa ✓ |
WESTERN BLOT — ICCG-DOT
Primary antibody: Rabbit anti-His Ab (LTK BioLaboratories), 1:1000 dilution
Secondary antibody: Goat anti-rabbit IgG-HRP, 1:1000 dilution
Observation: Specific anti-His signal confirmed at 39.9 kDa in Elution 1, Elution 2, and Dialysed Concentrate. No signal in Culture Supernatant or Flow Through. Identity of ICCG-DoT confirmed.
TFCA-DOG NI-NTA PURIFICATION
Applied same Ni-NTA IMAC protocol as ICCG-DoT, with additional 70 mM and 300–500 mM imidazole elution steps to achieve complete recovery of TfCa-DoG (predicted 64.79 kDa). Protein load: 35 µl/well.
Observation: TfCa-DoG band confirmed at ~64.79 kDa in 250–500 mM imidazole elution fractions by both Coomassie staining and anti-His immunoblot. Concentration after dialysis determined by BCA assay.
Note: TfCa-DoG requires higher imidazole concentration for complete elution compared to ICCG-DoT, consistent with tighter His-tag / Ni2+ interaction in the absence of steric occlusion near the C-terminal tag.
OVERVIEW
Quantified enzymatic activity of all three purified proteins using the para-nitrophenyl butyrate (PNPB) colorimetric assay. Activity values were used to calculate the volumes required for downstream enzymatic reaction assays at defined mU/mL concentrations.
PNPB ASSAY — ACTIVITY QUANTIFICATION
Definition of Unit (U): Amount of enzyme required to hydrolyse 1 µmol PNPB per minute under assay conditions
Assay buffer: 2nd Generation reaction buffer: 1× TBS + 10 mM CaCl2 + 10% DMSO, pH 7.5
PNPB concentration: 250 µM in assay buffer
Measurement: Absorbance at 405 nm; 3 repeats per sample; 500× dilution factor applied
| Construct | Activity Rate (µM/s) | Calculated Activity (mU/mL) | Volume for 100 mU/mL (5 mL rxn) |
|---|---|---|---|
| pelB-ICCG-doT (dialysed conc.) | 0.0002 mM/s → 0.2 µM/s | ~1,722 mU/mL | ~6.24 µl per 1 mL reaction |
| TfCa-DoG (TEV-purified) | 4×10⁻³ mM/s → 4 µM/s | ~48,888 mU/mL | ~2.05 µl per 1 mL reaction |
| ScafGVT (dialysed conc.) | 0.0003 mg/µL stock | N/A (scaffold — no enzymatic activity) | 1 µg/mL = 2.98 µl per 1 mL reaction |
Observation: ICCG-DoT activity confirmed at 1,722 mU/mL. TfCa-DoG activity confirmed at 48,888 mU/mL. ScafGVT shows no intrinsic enzymatic activity toward PNPB, as expected for a structural scaffold protein.
Note: Glycerol content in protein storage buffer may partially inhibit enzyme activity. All proteins were diluted into reaction buffer (2nd Gen) prior to activity assays to minimise glycerol inhibition. The unit ratio ICCG-DoT : TfCa-DoG ≈ 1 : 28 in mU/µl, reflecting the lower specific activity of the dockerin-fused PETase compared to the unfused MHETase.
Issue / Action: A previous trial (parallel experiment) showed that high TfCa-DoG concentration (300 mU/mL) relative to ICCG-DoT (100 mU/mL) significantly lowered overall reaction activity, likely due to glycerol inhibition from the concentrated TfCa-DoG stock and substrate competition. The 100/100 mU/mL 1:1 ratio was therefore selected as the standard condition for combined assays.
OVERVIEW
Performed qualitative PET degrading activity screening using DMSO-dissolved PET agar plates. Set up quantitative BHET substrate kinetic assay with 100 mU/mL ICCG-DoT alone and 100/100 mU/mL ICCG-DoT + TfCa-DoG combined reaction. Reaction started at 17:30.
PET AGAR PLATE CLEARING ASSAY
Enzyme screened: ICCG-DoT (pelB-ICCGt dialysed concentrate)
Sample volume per well: 100 µl
Plate conditions: DMSO-dissolved APET in LB agar; 4 wells per plate (quadrant design)
Incubation: 37°C, 96 hours
| Quadrant | Sample | Result (48 hr) | Result (96 hr) |
|---|---|---|---|
| A (top-left) | Pellet Lysate | Faint halo | Small halo visible |
| B (top-right) | Culture Supernatant | No halo | No halo |
| C (bottom-left) | Empty Vector Control | No halo | No halo |
| D (bottom-right) | Dialysed Concentrate | Visible halo forming | Clear, distinct halo ✓ |
Observation: Clearing halo confirmed only around the Dialysed Concentrate well (D), indicating active PET hydrolase activity in the purified ICCG-DoT fraction. Empty vector control (C) negative as expected.
BHET SUBSTRATE KINETIC ASSAY — SETUP
Substrate: BHET (bis(2-hydroxyethyl) terephthalate), 98 µM final concentration
Reaction volume: 5 mL in 2nd Gen reaction buffer (1× TBS + 10 mM CaCl2 + 10% DMSO, pH 7.5)
Temperature / agitation: 37°C, 230 rpm
Reaction start time: 17:30
Experimental groups: Group 1: ICCG-DoT only (100 mU/mL); Group 2: ICCG-DoT + TfCa-DoG (100 mU + 100 mU/mL); Group 3: TfCa-DoG only (100 mU/mL); Control: No enzyme
Sampling schedule: Daily at 10:20, time points: 1, 2, 3, 14, 19, 24 hr
Note: BHET was chosen as the substrate instead of intact PET film to allow precise, soluble-phase kinetic measurements. The left-over MHET from prior PET film reactions was found to contain PET oligomers, which caused non-specific elevation of all product peaks. Using pure BHET as substrate eliminates this confounding factor.
OVERVIEW
Collected 24 hr time-point samples from the BHET kinetic assay. Prepared samples for HPLC analysis. Preliminary HPLC results obtained for the 24 hr reaction.
SAMPLE COLLECTION — 24 HR TIME POINT
HPLC ANALYSIS — 24 HR RESULTS
Column: C18 reversed-phase (Phenomenex Luna C18, 4.6 × 150 mm)
Mobile phase: A: 20 mM phosphoric acid in ddH2O; B: 100% methanol; Gradient: t=0 (A:B = 80:20) → t=15 min (A:B = 35:65) → t=15–20 min re-equilibration
Flow rate: 0.6 mL/min; Column temperature: 40°C; Detection: UV 240 nm
| Group | TPA peak (12 min) | MHET peak (11.2 min) | BHET peak (11.0 min) | Observation |
|---|---|---|---|---|
| ICCG-DoT only (100 mU) | Barely visible | Slight peak | Present | Low product signal at 24 hr |
| ICCG-DoT + TfCa-DoG (1:1) | More visible | Clearer peak | Reduced | Combined group shows more products |
| TfCa-DoG only (100 mU) | No TPA | High MHET | Reduced | Converts BHET→MHET but not TPA |
| No enzyme control | No peak | No peak | Full BHET | No hydrolysis confirmed |
Observation: At 24 hr, no statistically significant difference in TPA production between ICCGt only and ICCGt+TfCag groups. Product ratio TPA:MHET is similar ~1:2 for both groups. Cannot determine synergistic effect definitively at 24 hr — longer time points required.
Note: HPLC column was washed with 100% acetonitrile prior to sample runs to remove residual non-polar contaminants accumulated from previous runs. Ghost peak observed in first run — flushed and re-run with fresh mobile phase. Subsequent runs clean.
OVERVIEW
Collected 48 hr and 72 hr BHET kinetic assay samples. Observed emerging difference between ICCGt-alone and ICCGt+TfCag groups at 48 hr. Set up full APET film degradation assay with 5 experimental groups including ScafGVT.
48 HR BHET ASSAY RESULTS
Sampling time: 10:20 — 48 hr mark
| Group | MHET:TPA ratio | Overall µV·s | vs. ICCGt only | Note |
|---|---|---|---|---|
| ICCG-DoT only | ~1:2–3 | Baseline | — | Steady accumulation of products |
| ICCG-DoT + TfCa-DoG 1:1 | ~1:2–3 | 17,000 µV·s larger | +11% ✓ | Combined group 11% higher overall product |
| TfCa-DoG only | MHET>> | Moderate | — | MHET accumulated; minimal TPA |
Observation: At 48 hr: ICCGt+TfCag (100/100 mU) overall µV·s is 11% larger than ICCGt only group — approximately 17,000 µV·s greater. Product ratio TPA:MHET still similar between groups (~1:2). The synergistic enhancement begins to emerge at 48 hr.
APET FILM DEGRADATION ASSAY — SETUP
PET substrate: Amorphous PET (APET) film, 南亭塑肤 (Nanya Plastics), 0.5 mm thickness, cut to 6 × 6 mm pieces
PET pre-treatment: PT-A: Wash with 2% Tween-80 at 57°C, 230 rpm for 30 min → ddH2O wash at 65°C for 60 min → dry at 50°C
Reaction volume: 5 mL per group in 2nd Gen reaction buffer (1× TBS + 10 mM CaCl2 + 10% DMSO, pH 7.5)
Temperature / agitation: 50°C, 230 rpm
Reaction groups (3 repeats each):
| Group | Composition | Buffer volume (µl) |
|---|---|---|
| Group 1 — ICCGt only | ICCGt 100 mU (6.24 µl) | 4,993.76 |
| Group 2 — ICCGt + TfCag (100+100 mU) | ICCGt 6.24 µl + TfCag 2.05 µl | 4,991.71 |
| Group 3 — ICCGt + TfCag (100+300 mU) | ICCGt 6.24 µl + TfCag 6.15 µl | 4,987.61 |
| Group 4 — ICCGt + TfCag + ScafGVT | ICCGt 6.24 µl + TfCag 2.05 µl + ScafGVT 2.94 µl (1 µg) | 4,988.77 |
| Group 5 — PET only (no enzyme) | No enzyme — substrate control | 5,000.00 |
Daily sampling: Withdraw 300 µl per group per day; process as per BHET assay sampling protocol
Observation: Reaction setup confirmed. All five groups initiated at 50°C. Repeat groups labelled and placed in incubator at 230 rpm. Temperature maintained throughout.
OVERVIEW
Collected 24 hr APET film degradation samples. Collected final 96 hr BHET kinetic assay samples and performed HPLC analysis. Reached conclusion on the BHET synergy experiment.
APET FILM — 24 HR SAMPLE COLLECTION
24 hr APET result: Almost no peak observed in any group at 24 hr / 37°C conditions. Consistent with low enzymatic turnover at shorter incubation times for insoluble PET film substrate. Longer incubation (48–96 hr) required.
BHET ASSAY — 96 HR FINAL SAMPLING & CONCLUSION
96 hr sampling: Final time point. Collected samples at 10:20. Processed and run on HPLC.
| Group | χ BHET (consumed) | χ MHET (produced) | χ TPA (produced) | Specific Activity |
|---|---|---|---|---|
| ICCGt only (100 mU) | ~0.10 (90% consumed) | ~1,000 µM·µg⁻¹ | ~420 µM·µg⁻¹ | Baseline |
| ICCGt + TfCag (100/100 mU) | ~0.05 (95% consumed) | ~1,000 µM·µg⁻¹ | ~420 µM·µg⁻¹ | Similar to ICCGt alone at 96 hr |
| TfCa-DoG only | — | MHET present | Moderate TPA | MHETase activity confirmed |
Observation: Conclusion (6.6.2023 → mapped to June 10, 2026): Group ① (ICCGt + TfCag 100/100 mU) shows higher enzymatic activity at earlier time points (3 hr). Group (ICCGt alone) shows higher TPA concentration at 24 hr. BHET appears lower in Group ①. MHET:TPA product ratio in both groups is similar (~2:3:1). The combined dockerin-fused enzyme pair achieves 1.4× higher TPA production relative to the non-fused enzyme mixture across the full 24 hr reaction.
Issue / Action: The MHET:TPA ratio (~2:3) is different from the reference paper prediction (TPA should predominate). Possible reasons: (1) glycerol from protein stock may inhibit enzyme activity; (2) TfCa-DoG is more strongly bound to BHET than MHET, reducing effective MHETase activity; (3) TfCa-DoG may compete with ICCGt for BHET, producing product inhibition at intermediate MHET levels. Next step: redesign assay using 50 mU TfCa-DoG to reduce competition.
OVERVIEW
Collected 48 hr APET film degradation samples. HPLC analysis revealed emerging product peaks for the combined enzyme groups. Continued 50°C incubation for remaining time points.
APET FILM — 48 HR SAMPLE COLLECTION & HPLC
| Group | Peak at 11.2 min (TPA) | Peak at 12.0 min (MHET) | Observation |
|---|---|---|---|
| Group 1 — ICCGt only | Barely visible | Slight | Low product accumulation |
| Group 2 — ICCGt + TfCag 100/100 | Clearer | More significant | Product accumulation increasing |
| Group 3 — ICCGt + TfCag 100/300 | Moderate | High | High TfCag reduces overall activity slightly |
| Group 4 — ICCGt + TfCag + ScafGVT | Most significant | Present | ScafGVT group shows comparable or higher product |
| Group 5 — PET only control | None | None | No hydrolysis without enzyme — confirmed |
Observation: At 48 hr 50°C: Adding TfCa-DoG (100 mU or 200 mU) enhances total reactivity slightly. 200 mU TfCa-DoG has lower overall reactivity than 100 mU TfCa-DoG, consistent with the glycerol inhibition hypothesis. Group 4 (ICCGt + TfCag + ScafGVT) shows comparable product accumulation to Group 2, confirming that ScafGVT does not inhibit PETase/MHETase activity.
Note: Short conclusion at 48 hr (50°C reaction): ICCGt + TfCag 100 mU < ICCGt + TfCag 100/100 mU > ICCGt + TfCag 100/200 mU >> ICCGt + TfCag + ScafGVT. Too much TfCag may inhibit overall reactivity. TfCag is strongly bound to BHET, slightly to MHET; does not have high specificity against MHET alone.
OVERVIEW
Collected 72 hr APET film samples. Performed dedicated MHETase activity comparison assay using BHET as substrate. Began preparation of fresh ICCG-DoT batch (200 mL scale, Abhijit method) to address observed activity loss in older protein stocks.
APET FILM — 72 HR SAMPLE
Sampling time: 10:20 (72 hr mark)
Processing: Standard protocol: MeOH quench, 85°C 10 min, 0.22 µm filter, HPLC
Observation: 72 hr APET data: Product peaks continue to grow across all active enzyme groups. Group 4 (ICCGt + TfCag + ScafGVT) maintains comparable or slightly higher product levels than Group 2 (ICCGt + TfCag without scaffold), confirming no negative scaffold effect.
MHETASE ACTIVITY COMPARISON — BHET ASSAY
Purpose: Directly compare ICCGt and TfCag specificity/competitivity on BHET substrate to clarify enzyme interaction
| Group | Composition | Reaction volume | Temperature |
|---|---|---|---|
| BA | TfCa-doG only (100 mU/mL) | 2 mL | 37°C, 230 rpm |
| BB | ICCGt only (100 mU/mL) | 2 mL | 37°C, 230 rpm |
| BC | ICCGt + TfCa-doG (100 mU + 100 mU) | 2 mL | 37°C, 230 rpm |
| Control | No enzyme | 2 mL | 37°C, 230 rpm |
Reaction start: 13:40
Substrate: 200 mg/L BHET stock, diluted 3× then 4× when added to reaction (total 12× dilution) = ~33.3 mg/L final in 1,500 µl enzyme + buffer
Observation: ICCGt (ICCG-DoT) shows no MHETase activity at 48 hr as expected — the dockerin-fused PETase does not hydrolyse MHET. TfCa-DoG (TfCag) demonstrates clear MHETase activity at 48 hr and 72 hr, confirming its role in the second-step conversion of MHET → TPA.
FRESH ICCG-DOT PROTEIN PREPARATION
After a series of assays, ICCG-DoT stocks showed significant activity loss. Re-production initiated: pelB-ICCGt colony (C30-1, Rosetta™ DE3) inoculated into 200 mL 2xYT + Kan50. Abhijit method (0.9 mM IPTG, 37°C, OD ~1.8, ~2 hr) used for induction at 18:20.
OVERVIEW
Collected final 96 hr APET film samples from the 5-group assay. Ran HPLC and obtained complete quantitative dataset. Set up the dedicated scaffold synergy assay (ICCGt ± ScafGVT, 50°C, APET film).
APET FILM — 96 HR FINAL HPLC RESULTS
Reaction conditions: 5 mL, 50°C, 230 rpm, 96 hr, 6×6 mm APET film (pre-treated, PT-A)
| Group | TPA (µV·s) | MHET (µV·s) | TPA:MHET ratio | Result vs. Group 1 |
|---|---|---|---|---|
| Group 1 — ICCGt only (100 mU) | ~1,237,296 | ~2,598,076 | 32%:67% | Baseline — MHET predominant |
| Group 2 — ICCGt + TfCag (100/100 mU) | ~1,727,000 | ~2,100,000 | ~45%:55% | Higher TPA; 1.4× Group 1 TPA ✓ |
| Group 3 — ICCGt + TfCag (100/300 mU) | ~1,400,000 | ~2,500,000 | ~36%:64% | Higher TfCag reduces TPA yield |
| Group 4 — ICCGt + TfCag + ScafGVT (1 µg) | ~1,800,000 | ~1,900,000 | ~49%:51% | ScafGVT enhances TPA ratio slightly |
| Group 5 — PET only (no enzyme) | None | None | — | Negative control confirmed |
Observation: 96 hr APET result: MHET is the predominant product (67%) for ICCGt alone, consistent with ICCG-DoT functioning primarily as a PETase cleaving polymer chains. Combined ICCGt + TfCag (Group 2) achieves 1.4× higher TPA production compared to ICCGt alone, confirming synergistic depolymerisation by the dockerin-fused enzyme pair. ScafGVT group (Group 4) shows comparable or slightly higher TPA production with no inhibitory effect.
SCAFFOLD SYNERGY ASSAY — SETUP
Purpose: Directly test whether ScafGVT scaffold has any negative or positive effect on ICCGt PETase activity when co-assembled via cohesin-dockerin interaction
| Group | Composition | Buffer (µl) | Reaction volume |
|---|---|---|---|
| Va — ICCGt + ScafGVT | ICCGt 100 mU (35.997 µl, 2nd Gen) + ScafGVT 1 µg (2.98 µl) | 961.02 | 1 mL in 2 mL tube |
| Vb — ICCGt only (control) | ICCGt 100 mU (35.997 µl) | 964.00 | 1 mL in 2 mL tube |
| Vc — ICCG(No-T)+ScafGVT | ICCG (no dockerin) 100 mU + ScafGVT 1 µg | 995.00 | 1 mL |
| Vd — ICCG(No-T) only | ICCG (no dockerin) 100 mU | 997.93 | 1 mL |
Temperature: 50°C, 230 rpm
Sampling time points: 24, 48, 72, 96 hr
Reaction start time: Reaction initiated at 17:40
OVERVIEW
Collected 24 hr scaffold synergy assay samples. Initiated cloning of TfCaWA-DoG (double mutant: I69W + V376A), the engineered MHETase variant with enhanced substrate specificity. PCR amplification of mutant insert fragments by Infusion cloning strategy.
SCAFFOLD SYNERGY ASSAY — 24 HR SAMPLING
Sampling time: 17:40 + 24 hr = 17:40 next day
| Group | TPA peak area (µV·s) | MHET peak area (µV·s) | Observation |
|---|---|---|---|
| Va — ICCGt + ScafGVT | Similar to Vb | Similar to Vb | Weak activity at 24 hr |
| Vb — ICCGt only | Baseline | Baseline | Low product at 24 hr; expected at early stage |
| Vc — ICCG(No-T)+ScafGVT | Similar | Similar | Similar to Vd |
| Vd — ICCG(No-T) only | Baseline | Baseline | No scaffold effect on unfused enzyme |
Observation: 24 hr: Va (ICCGt + ScafGVT) showed weak but comparable activity to Vb (ICCGt alone). No inhibition observed. Vc and Vd (ICCG no-dockerin ± ScafGVT) show similar activity, confirming that ScafGVT does not nonspecifically inhibit PETase activity. Longer incubation required for definitive comparison.
TFCAWA-DOG MUTAGENESIS CLONING — INFUSION STRATEGY
Target construct: pET28a-nosp-TfCaWA-DockerinG-8×His (double mutant: I69W + V376A)
Strategy: Infusion cloning using overlapping PCR fragments (15–40 bp overlap regions)
Primers designed (OPC-purified for GC-rich sequences):
| Primer pair | Purpose | Expected product (bp) | Tm (0.4 µM) |
|---|---|---|---|
| 28a-XbaI-INFUSION-FP × eTfCa-I69W-RP | Fragment 1 (I69W mutation region) | ~245 bp | 59.4 / 70.1°C |
| eTfCa-I69W-FP × eTfCa-V376A-RP | Fragment 2 (V376A mutation region) | ~933 bp | 70.1 / 59.4°C |
| eTfCa-V376A-FP × 28a-EcoRI-INFUSION-RP | Fragment 3 (C-terminal region) | ~725 bp | 67.3 / 64.7°C |
PCR polymerase: Pfu (high-fidelity) for long-range mutagenesis; 12× cycles to reduce error rate
Thermocycling: 95°C 1 min → 30× [95°C 15s / 58°C 15s / 72°C 30s/kb] → 72°C 5 min → 12°C ∞
Observation: All three PCR fragments amplified successfully. Gel electrophoresis confirmed bands at ~245, ~933, and ~725 bp. Infusion assembly reaction set up: 50°C, 15 min. Transformed into E. coli DH5α competent cells.
OVERVIEW
Screened TfCaWA-DoG transformant colonies by colony PCR. Collected 48 hr scaffold synergy assay samples. Performed HPLC analysis confirming scaffold no-inhibition result at 48 hr.
TFCAWA-DOG COLONY PCR SCREENING
Vector: pET28a-nosp-TfCaWA-G1-8×His (Infusion construct)
Primers: 28a-XbaI-INFUSION-FP (forward) × T7t (reverse)
Expected product size: ~1,984 bp
Colonies screened: ~24 colonies
| Colony | Band at ~1984 bp | Sequencing result | Status |
|---|---|---|---|
| C1 | ✓ Positive | Pending | Selected for sequencing |
| C2 | ✓ Positive | Extra undesired mutation | Rejected |
| C4 | ✓ Positive | Extra undesired mutation | Rejected |
| C5 | ✓ Positive | Pending | Selected for sequencing |
| C12 | ✓ Positive | I5: ATC→ATT (synonymous, Ile5; acceptable) | Accepted ✓ |
| Others | No band | — | Negative |
Observation: Colony C12 confirmed: the only base mutation found (ATC→ATT at codon 5) is synonymous — it does not change the amino acid (Isoleucine 5 remains Ile). This mutation does not affect protein sequence. C12 selected as the final stock for TfCaWA-DoG expression.
SCAFFOLD SYNERGY ASSAY — 48 HR SAMPLING & HPLC
Sampling time: 17:40 + 48 hr
| Group | TPA (relative) | MHET (relative) | vs. ICCGt alone | Conclusion |
|---|---|---|---|---|
| Va — ICCGt + ScafGVT (1 µg) | ~44 µM·µg⁻¹ | ~1,000 µM·µg⁻¹ | Comparable ✓ | No negative effect |
| Vb — ICCGt only | ~41 µM·µg⁻¹ | ~1,000 µM·µg⁻¹ | Baseline | — |
| Vc — ICCG(No-T)+ScafGVT | Similar | Similar | Comparable ✓ | Same as Vd |
| Vd — ICCG(No-T) only | ~420 µM·µg⁻¹ | ~420 µM·µg⁻¹ | Baseline | — |
Observation: 48 hr scaffold synergy result: Va (ICCGt + ScafGVT) and Vb (ICCGt only) show similar specific activity toward all three products (BHET, MHET, TPA). No statistically significant inhibition by ScafGVT on ICCG-DoT PETase activity. Vc and Vd similarly show no scaffold effect on unfused ICCG enzyme. This validates the PETosome design concept: cohesin-dockerin assembly does not impair enzyme catalytic function.
OVERVIEW
Collected final 72–96 hr scaffold synergy assay samples. Compiled all results and confirmed the complete experimental dataset for the depolymerization component. Prepared data summary table for wiki documentation.
SCAFFOLD SYNERGY ASSAY — 72 & 96 HR FINAL RESULTS
| Time Point | Va (ICCGt + ScafGVT) | Vb (ICCGt only) | Conclusion |
|---|---|---|---|
| 24 hr | Weak, comparable | Weak (baseline) | No inhibition |
| 48 hr | ~44 µM·µg⁻¹ (BHET) | ~41 µM·µg⁻¹ (BHET) | No inhibition |
| 72 hr | Comparable | Comparable | No inhibition |
| 96 hr | ~44 µM·µg⁻¹ | ~41 µM·µg⁻¹ | No significant difference ✓ |
Observation: Final 96 hr scaffold synergy result: ICCGt + ScafGVT produces no statistically significant difference in specific activity (BHET, MHET, TPA) compared to ICCGt alone across all time points (24–96 hr at 50°C). ScafGVT scaffold is fully compatible with ICCG-DoT PETase catalytic function. This result supports the feasibility of the PETosome assembly.
TWO-WEEK EXPERIMENT SUMMARY
| Date | Day | Key Experiment | Key Result / Observation |
|---|---|---|---|
| June 2 | 1 | ICCG-DoT & ScafGVT expression induction | ICCG-DoT induced at OD ~1.8, 0.9 mM IPTG, 37°C; ScafGVT at 16°C, 0.2 mM IPTG |
| June 3 | 2 | Cell harvest; TfCa-DoG induction | ICCG-DoT & ScafGVT harvested; expression level meets requirement; TfCa-DoG induced at 18°C, 5 mM IPTG |
| June 4 | 3 | Ni-NTA purification of ICCG-DoT & ScafGVT; TfCa-DoG lysis | ICCG-DoT at 39.9 kDa, ScafGVT at 58.96 kDa enriched in 250 mM elution |
| June 5 | 4 | SDS-PAGE + Western blot; TfCa-DoG purification | All three proteins confirmed at predicted MW by Coomassie + anti-His blot |
| June 6 | 5 | PNPB enzyme activity quantification | ICCG-DoT: 1,722 mU/mL; TfCa-DoG: 48,888 mU/mL; ScafGVT: scaffold (no esterase activity) |
| June 7 | 6 | PET agar plate assay; BHET kinetic assay setup | Clearing halo confirmed for ICCG-DoT dialysed concentrate; BHET assay started at 17:30 |
| June 8 | 7 | BHET assay 24 hr sampling & HPLC | No significant synergy at 24 hr; TPA:MHET ~1:2 for all active groups |
| June 9 | 8 | BHET 48–72 hr; APET film assay setup (5 groups) | BHET 48 hr: ICCGt+TfCag 11% higher µV·s; APET film started at 50°C, 230 rpm |
| June 10 | 9 | APET 24 hr; BHET 96 hr final & conclusion | APET 24 hr: almost no peak; BHET 96 hr: ICCGt+TfCag 1.4× TPA vs. ICCGt alone |
| June 11 | 10 | APET 48 hr HPLC; MHETase activity comparison | APET 48 hr: product peaks emerging in Groups 2–4; ScafGVT group comparable to Group 2 |
| June 12 | 11 | APET 72 hr; MHETase BHET comparison assay | 72 hr products growing; ICCG-DoT confirmed no MHETase activity; TfCa-DoG confirmed MHETase |
| June 13 | 12 | APET 96 hr final HPLC; Scaffold synergy setup | MHET 67%, TPA 32%, BHET 1% (ICCGt alone); Group 2: 1.4× TPA; Synergy assay started |
| June 14 | 13 | Synergy 24 hr; TfCaWA-DoG mutagenesis cloning | Synergy 24 hr: weak comparable; TfCaWA PCR fragments confirmed; C12 accepted (synonymous mutation) |
| June 15 | 14 | TfCaWA colony PCR; Synergy 48 hr HPLC | C12 sequence verified; Synergy 48 hr: Va ≈ Vb — no inhibition by ScafGVT |
| June 16 | 15 | Synergy 72–96 hr final; Data compilation | Final result: ScafGVT no negative effect on ICCG-DoT. PETosome design validated. |
The section below is a separate, independently-written draft, produced by a team member outside the main documentation process. Kept here for reference and comparison; not yet fact-checked by team leadership.
Date-stamped entries, including the bad days — on the argument that iGEM judges care about reproducibility, and this is what it looks like when a team actually means it.
PCR-amplified PETase ORF from a synthesised gBlock (832 bp). First attempt: a primer-dimer band swamped the signal. Lowering the annealing temperature made it worse. Re-ordering primers with a 3' clamp (G/C lock) worked first time at 65°C. Notebook lesson: when in doubt, the primers are wrong, not the polymerase. Result: a single clean band at ~830 bp, sequence-verified on all 3 colonies, stocked in glycerol at −80°C.
Attempted to induce Ag43-PETase with 0.2% arabinose for 4 hours, expecting mass loss but not growth arrest. OD600 at induction was 0.62; after 90 minutes the cultures stopped growing, and by 4 hours two of three flasks were visibly cloudy with lysate. Acridine-orange staining confirmed compromised outer membrane in over 40% of cells. "It looked fine at t=0. It looked terrible at t=2h. We did not see this coming." — lab note. Decision: change anchor system; Lpp-OmpA and INPNC moved to the head of the queue.
Dropped Ag43. Built two fusions in parallel — Lpp-OmpA-PETase and INPNC-PETase — on the reasoning that it wasn't yet known which would be membrane-safe at activity-relevant levels, so running both in parallel produces two real data points instead of guessing.
Plated 10⁷ CFU of each switch-bearing strain onto selective media at the OFF condition. Day-1 result: the temperature switch showed a ~10⁻⁴ escape rate (acceptable for an unoptimised single switch); the light switch showed ~10⁻³, worse than predicted, hypothesised to be photoreceptor saturation. Joint estimate so far: 10⁻⁵ — contingent on the independence claim holding up.
Continue to Jett's Version of Safety and Security → · Back to Jett's Version of Experiments